Logo
  • About
  • Contact
  • (888) 441-8033

InFlectis BioScience Completes Enrollment of its Phase 2 trial of IFB-088 for the Treatment of Amyotrophic Lateral Sclerosis; Anticipates Initial Results Later this Year

Nantes, France, January 31, 2024 -- InFlectis BioScience, a pioneer in developing first-in-class therapies for neuromuscular diseases, announced that it has completed enrollment in its Phase 2 clinical trial of IFB-088 ((INN: icerguastat), a novel investigational treatment of ...

View full release

Stonegate Capital Partners Updates Coverage on Alliance Resource Partners, L.P. (NASDAQ: ARLP) 2023 Q4

DALLAS, TX -- January 30th, 2024 -- Alliance Resource Partners, L.P. (NASDAQ: ARLP): Stonegate Capital Partners updates coverage on Alliance Resource Partners, L.P.  ARLP Releases Full Year 2023 and 4Q23 Earnings ARLP reported solid 4Q23 results that capped a record year, des...

View full release

A-Mark Foundation Launches New Resource Presenting Unbiased Facts on the Israeli-Palestinian Conflict

January 26, 2024 — Los Angeles, Calif. — A-Mark Foundation, a nonprofit organization dedicated to providing unbiased information on critical issues, launched a new resource aimed at answering 10 common questions about the Israeli-Palestinian conflict. The initiative comes in r...

View full release

Location Change, Speaker Update for the 2024 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit

SALT LAKE CITY -– January 22, 2024 – BioUtah, Utah’s trade association dedicated to the life sciences community, in partnership with the University of Utah’s Technology Licensing Office, today announced a venue change and speaker update for the 2024 Entrepreneur and Investor L...

View full release

RIVERDALE MILLS SEEKS LEGAL COSTS DEFENDING UNFOUNDED OSHA CHARGES

NORTHBRIDGE, MA -- After the U.S. Supreme Court late last year declined to hear a case involving alleged workplace violations brought by the Occupational Health and Safety Administration that bears directly on the currently contested authority of federal regulators, Riverdale ...

View full release

Pacylex Pharmaceuticals Reports Phase 1 Safety and Efficacy Results for Zelenirstat in Colorectal and other Cancers

Edmonton, Alberta, Canada January. 16, 2023. Pacylex Pharmaceuticals Inc. (Pacylex) is a clinical-stage pharmaceutical company focused on the development of a new class of targeted therapies, N-myristoyltransferase inhibitors (NMTi) for the treatment of hematologic and solid t...

View full release

Sistah Scifi Announces Nisi Shawl's West Coast Book Tour for 'Kinning', A Bold Sequel in the Realm of Afrofuturism

Oakland, CA, January 1st, 2024 -- Sistah Scifi, the first Black-owned bookstore focused on science fiction and fantasy, is proud to announce the West Coast Book Tour celebrating Nisi Shawl's sequel to Everfair, "Kinning," the follow-up to their acclaimed debut novel, "Everfair...

View full release

Stonegate Capital Partners Updates Coverage on U.S. Global Investors, Inc. (NASDAQ: GROW) Fiscal Q1 2024

DALLAS, TX -- January 12th, 2024 -- U.S. Global Investors, Inc. (NASDAQ: GROW): Stonegate Capital Partners updates their coverage on U.S. Global Investors, Inc.   Company Updates Well Positioned to Grow AUM: U.S. Global Investors offers 6 innovative and thematic no-load mutua...

View full release

Boomers Can Eat Cake and Buy Crypto ETFs

INDIANAPOLIS, IN - Sarson Funds, a leading provider of digital asset investment strategies, has announced that it will adjust focus away from investors between the ages of 58-78 for its crypto strategies. This decision, which was made in response to the disproportionate access...

View full release

UGI Offers Natural Gas and Electric Safety Advice While Preparing for Possible Flooding and High Winds

Heavy rain and high winds are forecasted for UGI’s service area Tuesday and Wednesday. With the potential of flooding and damaging wind conditions, UGI urges customers to be safe in dangerous weather. Always remember the following safety tips:  An odorant that smells like rott...

View full release
  • « First
  • ‹ Prev
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • Next ›
  • Last »
©2025 Reportable, Inc.
Terms and Conditions | Privacy Policy